Oryzon Genomics SA (ES:ORY) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oryzon Genomics SA announces a capital increase following an investor’s request to convert bonds into shares, resulting in the issuance of 255,400 new shares and a capital boost of nearly 480,000 euros. These new shares have also been admitted to trading on multiple Spanish stock exchanges.
For further insights into ES:ORY stock, check out TipRanks’ Stock Analysis page.